GVHD,ACUTE
Clinical trials for GVHD,ACUTE explained in plain language.
Never miss a new study
Get alerted when new GVHD,ACUTE trials appear
Sign up with your email to follow new studies for GVHD,ACUTE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise in preventing transplant complications
Disease control CompletedThis early-phase study tested whether adding a drug called BMS-986004 (which blocks CD40-L) to standard immune-suppressing medicine could help prevent acute graft-versus-host disease (GVHD) in 45 adults with blood cancers or disorders receiving a stem cell transplant. GVHD is a s…
Matched conditions: GVHD,ACUTE
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
Blood test may predict deadly transplant complication
Knowledge-focused CompletedThis study measured specific proteins in the blood of 500 stem cell transplant patients to see if they could predict acute graft-versus-host disease (aGVHD), a serious complication. Researchers tracked these proteins every two weeks for three months after transplant. The goal was…
Matched conditions: GVHD,ACUTE
Sponsor: Chinese PLA General Hospital • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC